See more : Chartwell Retirement Residences (CWSRF) Income Statement Analysis – Financial Results
Complete financial analysis of Westlake Chemical Partners LP (WLKP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Westlake Chemical Partners LP, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- LX Hausys, Ltd. (108670.KS) Income Statement Analysis – Financial Results
- Biotest Aktiengesellschaft (BIO3.DE) Income Statement Analysis – Financial Results
- Banyan Acquisition Corporation (BYN) Income Statement Analysis – Financial Results
- Forval RealStraight Inc. (9423.T) Income Statement Analysis – Financial Results
- CMG Holdings Group, Inc. (CMGO) Income Statement Analysis – Financial Results
Westlake Chemical Partners LP (WLKP)
About Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B | 1.29B | 1.17B | 986.74M | 1.01B | 1.75B | 2.13B | 2.25B | 2.25B |
| Cost of Revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M | 908.46M | 769.31M | 595.41M | 624.34M | 1.00B | 1.26B | 1.61B | 1.84B |
| Gross Profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M | 377.16M | 403.67M | 391.33M | 382.88M | 745.81M | 872.61M | 635.65M | 409.10M |
| Gross Profit Ratio | 32.54% | 23.69% | 36.36% | 39.19% | 34.75% | 29.34% | 34.41% | 39.66% | 38.01% | 42.63% | 41.01% | 28.26% | 18.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.09M | 26.62M | 28.58M | 22.16M | 26.95M | 24.62M | 27.26M | 21.97M | 20.68M | 21.30M | 24.05M | 22.49M | 0.00 |
| Selling & Marketing | 2.67M | 3.06M | 2.44M | 3.73M | 2.33M | 2.97M | 2.00M | 2.92M | 2.87M | 7.95M | 1.40M | 1.62M | 0.00 |
| SG&A | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Other Expenses | 0.00 | 1.57M | 62.00K | 733.00K | 3.10M | 2.46M | 1.79M | 601.00K | 160.00K | 3.15M | 7.70M | 4.19M | 2.80M |
| Operating Expenses | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Cost & Expenses | 833.08M | 1.25B | 804.17M | 613.68M | 741.72M | 936.05M | 798.57M | 620.29M | 647.89M | 1.03B | 1.28B | 1.64B | 1.87B |
| Interest Income | 0.00 | 13.41M | 8.82M | 12.04M | 19.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M | 21.43M | 21.86M | 12.61M | 4.97M | 10.50M | 8.03M | 8.94M | 8.95M |
| Depreciation & Amortization | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
| EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M | 460.87M | 490.18M | 464.92M | 440.51M | 797.32M | 928.32M | 679.99M | 444.78M |
| EBITDA Ratio | 39.65% | 29.52% | 42.77% | 47.26% | 42.18% | 35.85% | 41.79% | 47.15% | 43.75% | 45.57% | 43.63% | 30.23% | 19.76% |
| Operating Income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M | 349.57M | 374.41M | 366.44M | 359.33M | 716.56M | 847.16M | 611.55M | 384.79M |
| Operating Income Ratio | 30.04% | 21.82% | 33.81% | 36.52% | 32.07% | 27.19% | 31.92% | 37.14% | 35.68% | 40.95% | 39.81% | 27.19% | 17.09% |
| Total Other Income/Expenses | -22.27M | -11.84M | -8.75M | -11.31M | -16.53M | -18.98M | -20.07M | -12.01M | -4.81M | -7.35M | -331.00K | -4.75M | -6.14M |
| Income Before Tax | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M | 330.59M | 354.34M | 354.44M | 354.53M | 709.21M | 846.83M | 606.80M | 378.64M |
| Income Before Tax Ratio | 28.17% | 21.08% | 33.08% | 35.35% | 30.56% | 25.71% | 30.21% | 35.92% | 35.20% | 40.53% | 39.80% | 26.98% | 16.82% |
| Income Tax Expense | 813.00K | 1.02M | 549.00K | 564.00K | 728.00K | 22.00K | 1.28M | 1.04M | 672.00K | 199.39M | 300.28M | 210.88M | 131.67M |
| Net Income | 54.28M | 334.83M | 401.39M | 341.12M | 332.90M | 49.35M | 48.67M | 40.94M | 39.83M | 13.58M | 546.55M | 395.92M | 246.97M |
| Net Income Ratio | 4.56% | 21.02% | 33.04% | 35.29% | 30.49% | 3.84% | 4.15% | 4.15% | 3.95% | 0.78% | 25.69% | 17.60% | 10.97% |
| EPS | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.53 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| EPS Diluted | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.51 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| Weighted Avg Shares Out | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.24M | 28.39M | 27.06M | 27.06M | 27.06M | 25.37M | 25.37M | 25.37M |
| Weighted Avg Shares Out (Dil) | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.68M | 28.39M | 27.29M | 27.10M | 27.06M | 25.37M | 25.37M | 25.37M |
Westlake Chemical Partners Announce First Quarter 2024 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its first quarter 2024 earnings prior to the market opening on Wednesday, May 1, 2024. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on...
Westlake Chemical Partners Provides 2023 Tax Information
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (the “Partnership”) (NYSE: WLKP) today provided an update on the availability of the Partnership's 2023 Investor Tax Packages including Schedule K-1 for its common unitholders. The Partnership's 2023 K-1 tax packages are now available. The...
Westlake Chemical Partners LP Filed Annual Report
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on February 28, 2024. A copy of...
Westlake Chemical Partners Provides Update about Tax Information
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (the “Partnership”) (NYSE: WLKP) today provided an update on the expected availability of the Partnership's 2023 Investor Tax Packages including Schedule K-1 for its common unitholders. Historically, the Partnership's Investor Tax Packages have been available...
Westlake Chemical Partners LP (WLKP) Q4 2023 Earnings Call Transcript
Westlake Chemical Partners LP (WLKP) Q4 2023 Earnings Call Transcript
Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2023 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2023 of $14.3 million, or $0.41 per limited partner unit, a decrease of $2.5 million compared to fourth...
Westlake Chemical Partners Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its fourth quarter and full year 2023 earnings prior to the market opening on Tuesday, February 20, 2024. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m....
Westlake Chemical Partners LP Announces Fourth Quarter 2023 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 38th quarterly distribution announced by the Partnership...
Westlake Chemical Partners LP Announces Third Quarter 2023 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2023 of $13.2 million, or $0.37 per limited partner unit, compared to third quarter 2022 net income of...
Westlake Chemical Partners LP Announces Third Quarter 2023 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 37th quarterly distribution announced by the Partnership...
Source: https://incomestatements.info
Category: Stock Reports